Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

por Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Publicado 2013